<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01597076</url>
  </required_header>
  <id_info>
    <org_study_id>111118-SUS-NON-AGE-GP</org_study_id>
    <nct_id>NCT01597076</nct_id>
  </id_info>
  <brief_title>Effect of an Iridoid Enriched Beverage on Skin Autofluorescence</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tahitian Noni International, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Indonesia University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tahitian Noni International, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of this clinical trial are to evaluate the effectiveness of an iridoid
      enriched beverage containing noni and cornelian juices and olive leaf extract on advanced
      glycation end product levels.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>skin autofluorescence (akin advanced glycation end products)</measure>
    <time_frame>Baseline and week 8</time_frame>
    <description>skin autofluorescence with AGE reader</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">34</enrollment>
  <condition>Oxidative Stress</condition>
  <condition>Quality of Life</condition>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>60-240 mL/day</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>60 -240 mL/day dose group</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>iridoid enriched mixed fruit beverage</intervention_name>
    <description>Mixed fruit beverage consisting of noni (Morinda citrifolia) juice, Cornelian cherry (Cornus mas &amp; Cornus officinalis) puree and juice, olive (Olea europea) leaf extract, and other fruit juices and natural flavors</description>
    <arm_group_label>60-240 mL/day</arm_group_label>
    <other_name>TruAge Max</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and females age 25 to 60 years.

          -  Overweight or obese, defined as BMI 23.0 to 39.9 kg/m2.

          -  Impaired fasting glucose, defined as fasting blood glucose 100 to 125 mg/dl.

          -  Prehypertension or Grade 1 hypertension, defined as systolic blood pressure 120-159 mm
             Hg AND diastolic BP 80-99 mm Hg.

          -  Ability of the participant (in the investigator's opinion) to comprehend the full
             nature and purpose of the study including possible risks and side effects.

          -  Consent to the study and willing to comply with study procedures.

        Exclusion Criteria:

          -  Prescription medication use for hypertension, high cholesterol, diabetes, heart
             disease, cancer, liver disease, or AIDS/HIV 2.

          -  Intake of foods and/or dietary supplements that may confound study outcomes including
             any use of a noni-based dietary supplement in the last month.

          -  Regular use (&gt; 3 times per week over the past month) of any dietary supplement that
             contains &quot;super fruits&quot; or high antioxidant concentrations.

          -  Regular use (&gt; 3 times per week over the past month) of any dietary supplement
             intended to alter or regulate blood glucose levels.

          -  Any medical conditions or diseases that may affect subject safety or confound study
             results (in the opinion of the investigator).

          -  Pregnant or lactating female.

          -  History of alcohol, drug, or medication abuse.

          -  Current heavy smokers (1 or more packs/day).

          -  Allergies to any ingredient in the investigational products.

          -  Participation in another study with any investigational product.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Samuel Oetoro, dr MS SpGK</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indonesia University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Claude J Jensen, MS</last_name>
    <role>Study Director</role>
    <affiliation>Morinda Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Nutrition, Faculty of Medicine, University of Indonesia</name>
      <address>
        <city>Jakarta</city>
        <zip>10430</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 9, 2012</study_first_submitted>
  <study_first_submitted_qc>May 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 11, 2012</study_first_posted>
  <last_update_submitted>December 2, 2014</last_update_submitted>
  <last_update_submitted_qc>December 2, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 4, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Morinda citrifolia</keyword>
  <keyword>noni</keyword>
  <keyword>advanced glycation end products</keyword>
  <keyword>oxidative stress</keyword>
  <keyword>quality of life</keyword>
  <keyword>metabolic syndrome</keyword>
  <keyword>safety</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

